Dermata Therapeutics, Inc.

NasdaqCM:DRMA Stock Report

Market Cap: US$1.6m

Dermata Therapeutics Management

Management criteria checks 4/4

Dermata Therapeutics' CEO is Gerry Proehl, appointed in Dec 2014, has a tenure of 9.92 years. total yearly compensation is $392.00K, comprised of 71.4% salary and 28.6% bonuses, including company stock and options. directly owns 0.87% of the company’s shares, worth $14.27K. The average tenure of the management team and the board of directors is 9.1 years and 3.3 years respectively.

Key information

Gerry Proehl

Chief executive officer

US$392.0k

Total compensation

CEO salary percentage71.4%
CEO tenure9.9yrs
CEO ownership0.9%
Management average tenure9.1yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Dermata Therapeutics Q2 GAAP EPS of -$0.24

Aug 15

We're Hopeful That Dermata Therapeutics (NASDAQ:DRMA) Will Use Its Cash Wisely

Nov 22
We're Hopeful That Dermata Therapeutics (NASDAQ:DRMA) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Gerry Proehl's remuneration changed compared to Dermata Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$11m

Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$392kUS$280k

-US$8m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$8m

Mar 31 2023n/an/a

-US$9m

Dec 31 2022US$506kUS$318k

-US$10m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$11m

Dec 31 2021US$1mUS$136k

-US$10m

Sep 30 2021n/an/a

-US$8m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$4m

Dec 31 2020US$27kUS$27k

-US$3m

Compensation vs Market: Gerry's total compensation ($USD392.00K) is below average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Gerry's compensation has been consistent with company performance over the past year.


CEO

Gerry Proehl (65 yo)

9.9yrs

Tenure

US$392,000

Compensation

Mr. Gerald T. Proehl, also known as Gerry, is Co-founded at Dermata Therapeutics, Inc. He has been the Chief Executive Officer and President of Dermata Therapeutics, Inc. since December 2014, Chairman sinc...


Leadership Team

NamePositionTenureCompensationOwnership
Gerald Proehl
Founder9.9yrsUS$392.00k0.87%
$ 14.3k
David Hale
Co-Founder & Lead Independent Directorno dataUS$73.00k0.034%
$ 556.2
Kyri Van Hoose
Senior VP & CFO3.2yrsUS$442.25kno data
Christopher Nardo
Senior VP & Chief Development Officer9.4yrsUS$469.97k0.0076%
$ 124.1
Sean Proehl
Senior Director of Legal & Business Developmentno datano datano data
Maria Bedoya Toro Munera
Senior Vice President of Regulatory Affairs & Quality Assurance8.8yrsUS$27.04kno data

9.1yrs

Average Tenure

65yo

Average Age

Experienced Management: DRMA's management team is seasoned and experienced (9.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gerald Proehl
Founder3.6yrsUS$392.00k0.87%
$ 14.3k
David Hale
Co-Founder & Lead Independent Director9.9yrsUS$73.00k0.034%
$ 556.2
Stephen Mento
Independent Director3.3yrsUS$44.00kno data
Wendell Wierenga
Independent Director8.2yrsUS$50.00k0.017%
$ 280.9
Kathleen Scott
Independent Director3.3yrsUS$55.00k0.0081%
$ 132.8
Mary Fisher
Independent Director3.3yrsUS$47.50k0.0065%
$ 105.9
Andrew Sandler
Independent Director3.3yrsUS$49.00k0.0067%
$ 109.1
Brittany Bradrick
Independent Director2.8yrsUS$47.50k0.0065%
$ 105.9

3.3yrs

Average Tenure

65yo

Average Age

Experienced Board: DRMA's board of directors are considered experienced (3.3 years average tenure).